| 2007-08-01 |
Arsenic and diabetes and hypertension in human populations: A review |
Toxicology and Applied Pharmacology. 2007 Aug;222(3):298-304. |
 |
| 2010-05-17 |
Arsenic and metabolic syndrome |
The 3rd International Congress on Arsenic in the Environment, 2010. 2010 May 17-21:254-256. |
|
| 2011-01 |
Arsenic and type 2 diabetes and hypertension in human populations |
Health Hazards of Arsenic Poisoning Environmental: From Epidemic to Pandemic. 2011 Jan;Chapter 9:135-160. |
|
| 2006-09 |
Arsenic carcinogenesis in the skin |
Journal of Biomedical Science. 2006 Sep;13(5):657-666. |
|
| 2005-09 |
Arsenic dose and its relation to cardiovascular risk among residents in middle Taiwan |
Epidemiology. 2005 Sep;16(5):S25. |
|
| 2012-07 |
Arsenic exposure in pregnancy increases the risk of adverse birth outcomes of newborn in Taiwan |
Understanding the Geological and Medical Interface of Arsenic- As 2012: Proceedings of the 4th International Congress on Arsenic in the Environment, 22-27 July 2012, Cairns, Australia. 2012 Jul:157-158. |
|
| 2005-08-15 |
Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan |
Toxicology and Applied Pharmacology. 2005 Aug;206(3):299-308. |
|
| 2006-03-01 |
Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan [Erratum:Toxicology and Applied Pharmacology. 2005 Aug;206(3):299-308.] |
Toxicology and Applied Pharmacology. 2006 Mar;211(2):175. |
|
| 2004-01 |
Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-1 activity |
Journal of Investigative Dermatology. 2004 Jan;122(1):125-129. |
|
| 2005-08 |
Arsenic ingestion and increased microvascular disease risk: observations from the southwestern arseniasis-endemic area in Taiwan |
International Journal of Epidemiology. 2005 Aug;34(4):936-943. |
|
| 2006-09-21 |
Arsenic inhibits induction of cytochrome P450 1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatoma cells |
Journal of Hazardous Materials. 2006 Sep;137(2):716-722. |
|
| 2012-07 |
Arsenic metabolism, lactate dehydrogenase and electrocardiogram abnormality among residents in the arseniasis-endemic areas of southwestern Taiwan |
Understanding the Geological and Medical Interface of Arsenic- As 2012: Proceedings of the 4th International Congress on Arsenic in the Environment, 22-27 July 2012, Cairns, Australia. 2012 Jul:155-156. |
|
| 2012-07 |
Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan |
Chemosphere. 2012 Jul;88(4):432-438. |
|
| 2007-01 |
Arsenic methylation, urinary arsenic metabolites and human diseases: Current perspective |
Journal of Environmental Science and Health Part C-Environmental Carcinogenesis & Ecotoxicology Reviews. 2007 Jan;25(1):1-22. |
|
| 2007-12-01 |
Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells |
Toxicology and Applied Pharmacology. 2007 Dec;225(2):162-170. |
|
| 2014-12 |
Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-kappaB signaling in cervical cancer |
Annals of Surgical Oncology. 2014 Dec;21(4 Suppl.):687-695. |
|
| 2018-07 |
Arsenic, DNA damage, and cancers of bladder and kidney - a long-term follow-up of residents in arseniasis endemic area of north-eastern Taiwan |
Environmental Arsenic in a Changing World. 2018 Jul:317-318. |
|
| 2009-08 |
Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells |
Toxicology in Vitro. 2009 Aug;23(5):897-905. |
|
| 2005-11 |
Arsenite enhances tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 |
Toxicology and Applied Pharmacology. 2005 Nov;209(1):10-18. |
|
| 2005-11-01 |
Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase |
Toxicology and Applied Pharmacology. 2005 Nov;208(3):277-284. |
|
| 2010-02-15 |
Arsenite promotes centrosome abnormalities under a p53 compromised status induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) |
Toxicology and Applied Pharmacology. 2010 Feb 15;243(1):55-62. |
|
| 2016-03-22 |
Arsenite regulates prolongation of glycan residues of membrane glycoprotein: A pivotal study via wax physisorption kinetics and FTIR imaging |
International Journal of Molecular Sciences. 2016 Mar 22;17(3):Article number 427. |
|
| 2018-05-14 |
Arthroprotective effects of Cf-02 sharing structural similarity with quercetin |
International Journal of Molecular Sciences. 2018 May 14;19(5):Article number 1453. |
|
| 2020-08 |
Artificial intelligence approach fighting COVID-19 with repurposing drugs |
Biomedical Journal. 2020 Aug;43(4):355-362. |
|
| 2021-09-15 |
Artificial intelligence-assisted identification of genetic factors predisposing high-risk individuals to asymptomatic heart failure |
Cells. 2021 Sep 15;10(9):Article number 2430. |
|
